ArticleThe Journal of infectious diseases2020

Early Antiretroviral Therapy May Preserve Vaccine Responses in Human Immunodeficiency Virus-Infected Patients by Preventing Damage to Long-Lived Plasma Cells.

Anna Nilsson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.